Tipranavir and Ledipasvir: Interaction Details
- Tipranavir
- Aptivus
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Tipranavir and Ledipasvir interaction:
Ledipasvir
We don't have a separate drug information page for Ledipasvir. The FDA's drug directory lists it as part of Harvoni (ledipasvir and sofosbuvir). Read the Ledipasvir and Sofosbuvir drug information page → Have a question about Ledipasvir? Ask a pharmacist, free →
What Happens When You Take Tipranavir With Ledipasvir
What can happen when they are taken together (rated Major)
Decreased ledipasvir exposure and loss of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Because ledipasvir is a , giving it together with P-gp is not recommended, since a marked reduction in ledipasvir could result in reduced efficacy.1
The Tipranavir and Ledipasvir Interaction, Explained
Tipranavir may lower the amount of ledipasvir in your body. Ledipasvir is a hepatitis C medicine, and it is moved around by a pump in your body called . Tipranavir (an HIV medicine, taken with ritonavir) can speed up that pump, so ledipasvir may be cleared faster and may not reach levels high enough to clear the virus.
This is based on how the drugs are expected to behave, not on a large study of people taking both. Still, the combination is generally not recommended. Please don't stop or change either medicine on your own. Talk with your pharmacist or doctor, who can review your options and manage this safely.
Mechanism: Tipranavir (with ritonavir) is expected to induce intestinal , increasing efflux of ledipasvir, a P-gp . This would reduce ledipasvir exposure (/) and risk loss of virologic (reduced SVR).
- Direction: decreased ledipasvir exposure.
- Evidence: theoretical; magnitude not quantified here. Onset unspecified.
- Severity: major.
- Management: with P-gp is not recommended. Consider an alternative antiretroviral or HCV regimen, and involve HIV/HCV specialists.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Tipranavir and Ledipasvir Interact
The likely mechanism
of -mediated ledipasvir efflux transport
How to Manage the Tipranavir and Ledipasvir Interaction
Your care team can manage this, usually by reviewing your regimen before or during treatment.
- of ledipasvir with like tipranavir is not recommended, so your team may consider a different HIV or hepatitis C medicine.
- Keep taking both medicines as prescribed until your prescriber tells you otherwise.
- Tell your pharmacist and doctor about every medicine and supplement you take.
- Ask whether your regimen needs to be reviewed, and whether you should be monitored more closely.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Tipranavir or Ledipasvir need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: HARVONI oral tablets, ledipasvir sofosbuvir oral tablets
In a study of healthy volunteers (N=31), oral of a single 90 mg dose of ledipasvir with rifampin 600 mg/day (a ) lowered ledipasvir by 35% and by 59%, relative to ledipasvir given alone.1
Tipranavir and Ledipasvir: Common Questions
How serious is the Tipranavir and Ledipasvir interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Tipranavir and Ledipasvir interaction managed?
Your care team can manage this, usually by reviewing your regimen before or during treatment. of ledipasvir with like tipranavir is not recommended, so your team may consider a different HIV or hepatitis C medicine. Keep taking both medicines as prescribed until your prescriber tells you otherwise. Tell your pharmacist and doctor about every medicine and supplement y… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Tipranavir and Ledipasvir Interaction
Ask in your own words about taking Tipranavir and Ledipasvir together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: HARVONI(R) oral tablets, ledipasvir sofosbuvir oral tablets. Gilead Sciences, Inc. (per manufacturer), Foster City, CA, 2014. DailyMed
Other Serious Interactions of Tipranavir and Ledipasvir
Also serious with Tipranavir
- ColchicineContraindicated
- SimvastatinContraindicated
- AlfuzosinContraindicated
- Dihydroergotamine InjectionContraindicated
Also serious with Ledipasvir
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Tipranavir
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- Vitamin EModerate
- GingerModerate
- TurmericModerate
- Green TeaModerate
- Black PepperModerate
- + 209 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.